N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide
C17H21N3O3S — CID 170191751
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide
N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide (PubChem CID 170191751) has the molecular formula C17H21N3O3S and a molecular weight of 347.44 g/mol. Its IUPAC name is N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide.
Molecular Properties
| Compound Name | N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide |
|---|---|
| PubChem CID | 170191751 |
| Molecular Formula | C17H21N3O3S |
| Molecular Weight | 347.44 g/mol |
| Exact Mass | 347.13 |
| IUPAC Name | N-[(3S)-2,6-dioxopiperidin-3-yl]-2-methyl-N-prop-1-en-2-yl-5-[(sulfanylamino)methyl]benzamide |
| SMILES | C=C(C)N(C(=O)c1cc(CNS)ccc1C)[C@H]1CCC(=O)NC1=O |
| InChI | InChI=1S/C17H21N3O3S/c1-10(2)20(14-6-7-15(21)19-16(14)22)17(23)13-8-12(9-18-24)5-4-11(13)3/h4-5,8,14,18,24H,1,6-7,9H2,2-3H3,(H,19,21,22)/t14-/m0/s1 |
| InChIKey | CNGSKHABRCSREO-AWEZNQCLSA-N |
| XLogP | 1.71 |
| TPSA | 78.51 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 347.44 |
| LogP ≤ 5 | 1.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170191751 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.